Table 2. Input Parameters of Decision Tree Model.
Parameter | Probability | 95% Confidence Interval (CI) | References |
---|---|---|---|
Probabilities | |||
INR in range (in standard dosing group) | 0.44 | 0.242 - 0.634 | (18) |
INR in range (in genotype - guided dosing group) | 0.562 | 0.37 - 0.754 | (18) |
INR out of range (in standard dosing group) | 0.56 | calculated | (18) |
INR out of range (in genotype - guided dosing group) | 0.438 | calculated | (18) |
Thromboembolism (within therapeutic INR range) | 0.02 | 0.01 - 0.03 | (23) |
Thromboembolism (out of therapeutic INR range) | 0.06 | 0.03 - 0.1 | (23) |
Bleeding (within therapeutic INR range) | 0.027 | 0.013 - 4.02 | (23) |
Bleeding (out of therapeutic INR range) | 0.093 | 0.022 - 0.093 | (23) |
ICH | 0.29 | 0.23 - 0.35 | (25) |
ECH | 0.71 | - | (25) |
Stroke | 0.6 | 0.48 - 0.72 | (25) |
TIA | 0.4 | - | (25) |
Utilities | |||
Standard dosing | 0/696 | 0.458 - 0.934 | Calculated |
Genotype - guided dosing | 0/760 | 0.524 - 0.996 | Calculated |
ICH | - 0.14 | - 0.12 to - 0.16 | (25) |
ECH | - 0.06 | - 0.02 to - 0.1 | (25) |
TIA | - 0.103 | - 0.088 to - 0.119 | (25) |
Stroke | - 0.14 | - 0.12 to - 0.16 | (25) |
Sequelae | - 0.374 | - 0.16 to - 0.374 | (25) |
Death | 0.0 | - | (25) |
Costs | |||
Genotyping | 187.5 | - | National tariffs |
INR monitoring | 16 | - | National tariffs |
ICH | 241 | - | National tariffs |
ECH | 205 | - | National tariffs |
TIA | 178 | - | National tariffs |
Stroke | 311 | - | National tariffs |
Sequelae | 21.5 | - | National tariffs |
Abbreviations: ECH, extracranial haemorrhage; ICH, intracranial haemorrhage; INR, international normalized ratio; TIA transient ischemic attack.